CSIMarket


Terms Beginning with P
       
       
 

Phase I Clinical Trial

Health Care Term


Phase I clinical trial is the first step of testing new drugs or medical interventions in human subjects to evaluate the safety, tolerability, and pharmacological properties of the intervention. This trial usually involves a small group of healthy volunteers or individuals with the target disease who have not undergone any treatment before. The primary goal of a phase I trial is to determine the highest safe dose of the new intervention and assess its toxicity and adverse effects.

During a phase I clinical trial, researchers collect data on various parameters such as the drug's pharmacodynamics, pharmacokinetics, and metabolic profile. They also evaluate the drug's efficacy, including its ability to target and interact with the intended biological targets. The trial is designed to identify the optimal dosage and administration regimen, as well as the drug's safety and tolerability profile.

Phase I clinical trials are essential in the health care industry as they provide critical information on the safety and feasibility of a new intervention. The trial's results can help researchers and regulatory agencies decide whether to proceed with further clinical testing in Phase II and III trials or discontinue development due to safety concerns. In addition, phase I trials are instrumental in informing physicians and patients about the potential risks and benefits of new interventions, aiding in the informed decision-making process. Overall, phase I clinical trials advance the understanding of the biology and the development of better treatments for patients.


   
     

Phase I Clinical Trial

Health Care Term


Phase I clinical trial is the first step of testing new drugs or medical interventions in human subjects to evaluate the safety, tolerability, and pharmacological properties of the intervention. This trial usually involves a small group of healthy volunteers or individuals with the target disease who have not undergone any treatment before. The primary goal of a phase I trial is to determine the highest safe dose of the new intervention and assess its toxicity and adverse effects.

During a phase I clinical trial, researchers collect data on various parameters such as the drug's pharmacodynamics, pharmacokinetics, and metabolic profile. They also evaluate the drug's efficacy, including its ability to target and interact with the intended biological targets. The trial is designed to identify the optimal dosage and administration regimen, as well as the drug's safety and tolerability profile.

Phase I clinical trials are essential in the health care industry as they provide critical information on the safety and feasibility of a new intervention. The trial's results can help researchers and regulatory agencies decide whether to proceed with further clinical testing in Phase II and III trials or discontinue development due to safety concerns. In addition, phase I trials are instrumental in informing physicians and patients about the potential risks and benefits of new interventions, aiding in the informed decision-making process. Overall, phase I clinical trials advance the understanding of the biology and the development of better treatments for patients.


Related Health Care Terms
                     
                     
 Adenocarcinoma   Analogues   Arrhythmia  
 Adenosine   ANDA Abbreviated New Drug Application   Arteriosclerosis  
 Adult Stem Cell   Angina   Atherosclerosis  
 Adverse Event   Angiogenesis   Autologous  
 Agonist   Angioplasty   Balloon Angioplasty  
 AIDS   Antagonist   Bioavailability  
 Alkylation Agent   Anti Hypertensive   Biologic Products  
 Allogeneic   Antibody   Biomarker  
 Amino Acid   Antigen   Bradycardia  
 Analgesic   API   Cancer  
               
                  next arrow
 
   


Help

About us

Advertise